• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人 CD34(+) 干细胞/祖细胞移植逆转大鼠肝纤维化。

Reversal of Hepatic Fibrosis by Human CD34(+) Stem/Progenitor Cell Transplantation in Rats.

机构信息

Departments of Medical Biochemistry, Faculty of Medicine, Ain Shams University.

Medical Biochemistry, Faculty of Medicine, Ain Shams University.

出版信息

Int J Stem Cells. 2010 May;3(2):161-74. doi: 10.15283/ijsc.2010.3.2.161.

DOI:10.15283/ijsc.2010.3.2.161
PMID:24855554
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4021810/
Abstract

Human umbilical cord blood (UCB) cells have many advantages as grafts for cell transplantation. Here, we transplant UCB cells into injured liver fibrosis, investigated the hepatic potential of UCB cells both in vitro and in vivo. a CCl4 rat model with liver fibrosis was prepared. Human (UCB) CD34(+) stem cell was separated with MACS (magnetic cell sorting). Cells were cultured with and without hepatic differentiation medium. Rats were divided into 3 groups; group (1): control healthy, group (2): CCl4 injected rats and group 3: CCl4/CD34(+)injected rats with human differentiated and undifferentiated cells through intrahepatic (IH) and intravenous (IV) routes. A significant elevation was detected in serum albumin in CCl4/CD34(+) compared to the CCl4 group (p<0.001). Serum ALT, had a significant decrease of its level after administration of stem cells compared to the CCl4 group (p<0.001). However, it was still significantly higher than control (p<0.001) with no significant difference between the groups that received stem cells. Histopathological examination of liver tissue showed that stem cells have a significant antifibrotic effect. Concerning gene expression, the collagen gene (rat) was highly expressed in the CCl4 group whereas its expression was significantly decreased after administration of stem cells. Human albumin and matrix metalloproteinase (MMP2) genes were expressed in liver tissues in the groups that received stem cells. Highest expression was in the group that received un-differentiated cells I.V. human UCB CD34(+) stem cells can ameliorate liver fibrosis in rats.

摘要

人脐带血(UCB)细胞作为细胞移植移植物具有许多优势。在这里,我们将 UCB 细胞移植到损伤的肝纤维化中,研究了 UCB 细胞在体外和体内的肝潜能。制备了 CCl4 诱导的大鼠肝纤维化模型。用 MACS(磁细胞分选)分离人(UCB)CD34(+)干细胞。细胞在有和没有肝分化培养基的情况下进行培养。大鼠分为 3 组:组 1:健康对照组,组 2:CCl4 注射大鼠组和组 3:通过肝内(IH)和静脉(IV)途径注射 CCl4/CD34(+)的大鼠。与 CCl4 组相比,CCl4/CD34(+)组血清白蛋白明显升高(p<0.001)。与 CCl4 组相比,干细胞给药后血清 ALT 水平显著降低(p<0.001)。然而,与对照组相比,其水平仍然显著升高(p<0.001),而接受干细胞的各组之间没有显著差异。肝组织学检查显示,干细胞具有显著的抗纤维化作用。关于基因表达,胶原基因(大鼠)在 CCl4 组中高度表达,而在给予干细胞后其表达显著降低。在接受干细胞的各组中,肝脏组织中表达了人白蛋白和基质金属蛋白酶(MMP2)基因。未分化细胞静脉内给药的组表达最高。人 UCB CD34(+)干细胞可改善大鼠肝纤维化。

相似文献

1
Reversal of Hepatic Fibrosis by Human CD34(+) Stem/Progenitor Cell Transplantation in Rats.人 CD34(+) 干细胞/祖细胞移植逆转大鼠肝纤维化。
Int J Stem Cells. 2010 May;3(2):161-74. doi: 10.15283/ijsc.2010.3.2.161.
2
Comparison of the therapeutic effectiveness of human CD34 and rat bone marrow mesenchymal stem cells on improvement of experimental liver fibrosis in Wistar rats.人CD34细胞与大鼠骨髓间充质干细胞对改善Wistar大鼠实验性肝纤维化治疗效果的比较。
Int J Physiol Pathophysiol Pharmacol. 2016 Sep 30;8(3):128-139. eCollection 2016.
3
Umbilical Cord Wharton's Jelly-Derived Mesenchymal Stem Cells Inhibit the TGF-β1 Pathway in Hepatic Fibrosis Rats Through a Paracrine Regulation Process.脐带华通氏胶源性间充质干细胞通过旁分泌调节过程抑制肝纤维化大鼠的TGF-β1信号通路。
Clin Lab. 2023 Jan 1;69(1). doi: 10.7754/Clin.Lab.2022.220357.
4
The therapeutic effects of bone marrow-derived mesenchymal stem cells and simvastatin in a rat model of liver fibrosis.骨髓间充质干细胞和辛伐他汀对肝纤维化大鼠模型的治疗作用。
Cell Biochem Biophys. 2014 Jan;68(1):111-25. doi: 10.1007/s12013-013-9698-1.
5
The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis.来自华通氏胶的人脐带间充质干细胞在大鼠肝纤维化治疗中的治疗潜力。
Liver Transpl. 2009 May;15(5):484-95. doi: 10.1002/lt.21715.
6
Preconditioning of Adipose-Derived Mesenchymal Stem-Like Cells with Eugenol Potentiates Their Migration and Proliferation In Vitro and Therapeutic Abilities in Rat Hepatic Fibrosis.丁香酚预处理脂肪间充质干细胞样细胞增强其体外迁移和增殖能力,并在大鼠肝纤维化中增强其治疗能力。
Molecules. 2020 Apr 26;25(9):2020. doi: 10.3390/molecules25092020.
7
Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis.骨髓间充质干细胞对实验性肝纤维化的治疗潜力
Clin Biochem. 2007 Aug;40(12):893-9. doi: 10.1016/j.clinbiochem.2007.04.017. Epub 2007 May 3.
8
[Pooled Umbilical Cord Blood Plasma for Culturing UCMSC and Ex Vivo Expanding Umbilical Cord Blood CD34⁺ Cells].用于培养脐带间充质干细胞和体外扩增脐带血CD34⁺细胞的混合脐带血血浆
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015 Aug;23(4):1112-9. doi: 10.7534/j.issn.1009-2137.2015.04.040.
9
Analyses to clarify rich fractions in hepatic progenitor cells from human umbilical cord blood and cell fusion.旨在阐明来自人脐带血的肝祖细胞中的富集组分及细胞融合的分析。
Biochem Biophys Res Commun. 2004 Nov 12;324(2):711-8. doi: 10.1016/j.bbrc.2004.09.115.
10
Human Liver Stem Cell Transplantation Alleviates Liver Fibrosis in a Rat Model of CCl-Induced Liver Fibrosis.人肝干细胞移植减轻四氯化碳诱导的大鼠肝纤维化模型中的肝纤维化
Int J Stem Cells. 2021 Nov 30;14(4):475-484. doi: 10.15283/ijsc21031.

引用本文的文献

1
Comparison of the therapeutic effectiveness of human CD34 and rat bone marrow mesenchymal stem cells on improvement of experimental liver fibrosis in Wistar rats.人CD34细胞与大鼠骨髓间充质干细胞对改善Wistar大鼠实验性肝纤维化治疗效果的比较。
Int J Physiol Pathophysiol Pharmacol. 2016 Sep 30;8(3):128-139. eCollection 2016.

本文引用的文献

1
Multipotent progenitor cells derived from human umbilical cord blood can differentiate into hepatocyte-like cells in a liver injury rat model.源自人脐带血的多能祖细胞在肝损伤大鼠模型中可分化为肝细胞样细胞。
Transplant Proc. 2009 Dec;41(10):4357-60. doi: 10.1016/j.transproceed.2009.08.053.
2
Differentiation of human umbilical cord mesenchymal stromal cells into low immunogenic hepatocyte-like cells.人脐带间充质基质细胞向低免疫原性肝细胞样细胞的分化
Cytotherapy. 2009;11(4):414-26. doi: 10.1080/14653240902849754.
3
Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study.间充质干细胞疗法对多发性硬化症患者有帮助吗?一项试点研究报告。
Iran J Immunol. 2007 Mar;4(1):50-7.
4
Human cord blood CD34+ cells develop into hepatocytes in the livers of NOD/SCID/gamma(c)null mice through cell fusion.人脐带血CD34+细胞通过细胞融合在NOD/SCID/γ(c)基因敲除小鼠的肝脏中发育为肝细胞。
FASEB J. 2007 Nov;21(13):3499-510. doi: 10.1096/fj.06-6109com. Epub 2007 Jun 18.
5
Generation of human/rat xenograft animal model for the study of human donor stem cell behaviors in vivo.建立人/大鼠异种移植动物模型用于研究人供体干细胞在体内的行为。
World J Gastroenterol. 2007 May 21;13(19):2707-16. doi: 10.3748/wjg.v13.i19.2707.
6
Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis.骨髓间充质干细胞对实验性肝纤维化的治疗潜力
Clin Biochem. 2007 Aug;40(12):893-9. doi: 10.1016/j.clinbiochem.2007.04.017. Epub 2007 May 3.
7
Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.急性心肌梗死中的冠状动脉内骨髓源性祖细胞
N Engl J Med. 2006 Sep 21;355(12):1210-21. doi: 10.1056/NEJMoa060186.
8
Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers.源自人间充质干细胞的肝细胞向小鼠肝脏的功能整合。
Gut. 2007 Mar;56(3):405-15. doi: 10.1136/gut.2005.090050. Epub 2006 Aug 23.
9
In vitro differentiation of human placenta-derived multipotent cells into hepatocyte-like cells.人胎盘来源的多能细胞体外分化为肝细胞样细胞。
Stem Cells. 2006 Jul;24(7):1759-68. doi: 10.1634/stemcells.2005-0521.
10
Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease.在终末期肝病患者中应用粒细胞集落刺激因子(G-CSF)诱导骨髓源性细胞动员的可行性和安全性。
J Hepatol. 2006 Jul;45(1):13-9. doi: 10.1016/j.jhep.2006.02.018. Epub 2006 Apr 6.